Status: current, Defined. Date: 31-Mar 2015. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1388111000168114 | abacavir 600 mg + dolutegravir 50 mg + lamivudine 300 mg tablet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
1388121000168119 | dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet | Is a | dolutegravir 50 mg + lamivudine 300 mg tablet | true | Inferred relationship | Some | ||
dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet | Is a | medicinal product unit of use | false | Inferred relationship | Some | ||
dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet | Is a | dolutegravir + abacavir + lamivudine | true | Inferred relationship | Some | ||
dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet | has intended active ingredient | dolutegravir | true | Inferred relationship | Some | 1295865802 | |
dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet | has Australian BoSS | dolutegravir | true | Inferred relationship | Some | 1295865802 | |
dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet | has intended active ingredient | abacavir | true | Inferred relationship | Some | 1990283938 | |
dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet | has Australian BoSS | abacavir | true | Inferred relationship | Some | 1990283938 | |
dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet | has intended active ingredient | lamivudine | true | Inferred relationship | Some | 990050302 | |
dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet | has Australian BoSS | lamivudine | true | Inferred relationship | Some | 990050302 | |
dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1990283939 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Trelavue tablet | Is a | True | dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet | Inferred relationship | Some | |
Triumeq tablet | Is a | True | dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet | Inferred relationship | Some | |
dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet, 30 | has MPUU | True | dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set